Beam Therapeutics Ownership | Who Owns Beam Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Beam Therapeutics Ownership Summary

Beam Therapeutics is owned by 95.85% institutional investors, 1.42% insiders, and 2.73% retail investors. Farallon capital management is the largest institutional shareholder, holding 9.69% of BEAM shares. ARK Innovation ETF is the top mutual fund, with 5.18% of its assets in Beam Therapeutics shares.

BEAM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Beam Therapeutics	95.85%	1.42%	2.73%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Farallon capital management	7.91M	9.69%	$185.40M
Vanguard group	7.90M	9.67%	$185.11M
Blackrock	7.63M	9.34%	$178.87M
Ark investment management	7.63M	9.33%	$178.68M
Arch venture management	5.44M	6.66%	$127.53M
Fmr	4.41M	5.40%	$103.27M
State street	3.49M	4.27%	$81.82M
Mwg management	2.27M	2.77%	$53.11M
Sumitomo mitsui trust	2.22M	2.72%	$52.12M
Nikko asset management americas	2.22M	2.72%	$52.07M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mwg management	2.27M	58.01%	$53.11M
Arch venture management	5.44M	47.94%	$127.53M
Redmile group	1.70M	2.41%	$39.90M
Yiheng capital management	845.50K	1.60%	$19.81M
Ark investment management	7.63M	1.59%	$178.68M
Casdin capital	675.00K	1.21%	$15.82M
Farallon capital management	7.91M	0.87%	$185.40M
Tang capital management	270.00K	0.64%	$6.33M
Nikko asset management americas	2.22M	0.60%	$52.07M
Bellevue group	1.42M	0.54%	$33.23M

Top Buyers

Holder	Shares	% Assets	Change
Arch venture management	5.44M	47.94%	5.44M
Farallon capital management	7.91M	0.87%	3.40M
First trust advisors lp	1.48M	0.04%	1.48M
Blackrock	7.63M	0.00%	928.75K
Deutsche bank ag\	861.99K	0.01%	801.24K

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	803.83K	0.00%	-3.32M
Darwin global management	-	-	-2.12M
Ark investment management	7.63M	1.59%	-556.03K
Fmr	4.41M	0.01%	-486.76K
Cormorant asset management, lp	-	-	-300.00K

New Positions

Holder	Shares	% Assets	Change	Value
Arch venture management	5.44M	47.94%	5.44M	$127.53M
First trust advisors lp	1.48M	0.04%	1.48M	$34.73M
Norges bank	410.80K	0.00%	410.80K	$9.63M
Mirae asset global etfs	174.18K	0.01%	174.18K	$4.08M
Bank of montreal /can/	151.07K	0.00%	151.07K	$3.68M

Sold Out

Holder	Change
Assetmark	-8.00
Nelson, van denburg & campbell wealth management group	-14.00
Piscataqua savings bank	-50.00
Macroview investment management	-80.00
Cassady schiller wealth management	-84.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	225	1.81%	78,990,351	1.88%	95	1.08%	102	-5.56%	66	4.76%
Jun 30, 2024	219	-6.01%	77,530,743	10.73%	94	1.15%	107	-21.90%	62	31.91%
Mar 31, 2024	233	19.49%	70,020,592	1.73%	90	1.20%	137	33.01%	47	-11.32%
Dec 31, 2023	195	-2.50%	68,827,655	2.56%	87	1.13%	103	-7.21%	53	26.19%
Sep 30, 2023	200	-0.99%	67,110,009	4.58%	87	1.12%	111	11.00%	42	-2.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Innovation ETF	4.27M	5.18%	51.83K
ARK Disruptive Innovation Full Composite	4.25M	5.15%	-941.74K
Vanguard Total Stock Mkt Idx Inv	2.32M	2.80%	-16.73K
Nikko AM ARK Disruptive Innovation A USD	2.26M	2.74%	-34.55K
SPDR® S&P Biotech ETF	2.06M	2.50%	22.84K
iShares Russell 2000 ETF	1.97M	2.37%	-4.42K
ARK Genomic Revolution	1.94M	2.35%	-129.03K
ARK Genomic Revolution ETF	1.93M	2.35%	9.31K
Vanguard Small Cap Index	1.86M	2.25%	3.65K
BB Biotech AG Ord	1.52M	1.84%	100.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 06, 2024	Ciaramella Giuseppe	President	Sell	$1.35M
Oct 14, 2024	Ciaramella Giuseppe	President	Sell	$1.34M
Oct 01, 2024	Bellon Christine	Chief Legal Officer	Sell	$9.04K
Oct 01, 2024	Cavanagh Bethany J	SVP, Finance and Treasurer	Sell	$6.79K
Sep 30, 2024	Evans John M.	CEO	Sell	$1.48M

Insider Transactions Trends

Date	Buy	Sell
2033 Q2	-	-
2024 Q4	-	2
2024 Q3	-	3
2024 Q2	-	7
2024 Q1	-	7

BEAM Ownership FAQ

Who Owns Beam Therapeutics?

Beam Therapeutics shareholders are primarily institutional investors at 95.85%, followed by 1.42% insiders and 2.73% retail investors. The average institutional ownership in Beam Therapeutics's industry, Biotech Stocks , is 47.04%, which Beam Therapeutics exceeds.

Who owns the most shares of Beam Therapeutics?

Beam Therapeutics’s largest shareholders are Farallon capital management (7.91M shares, 9.69%), Vanguard group (7.9M shares, 9.67%), and Blackrock (7.63M shares, 9.34%). Together, they hold 28.70% of Beam Therapeutics’s total shares outstanding.

Does Blackrock own Beam Therapeutics?

Yes, BlackRock owns 9.34% of Beam Therapeutics, totaling 7.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 178.87M$. In the last quarter, BlackRock increased its holdings by 928.75K shares, a 13.85% change.

Who is Beam Therapeutics’s biggest shareholder by percentage of total assets invested?

Mwg management is Beam Therapeutics’s biggest shareholder by percentage of total assets invested, with 58.01% of its assets in 2.27M Beam Therapeutics shares, valued at 53.11M$.

Who is the top mutual fund holder of Beam Therapeutics shares?

ARK Innovation ETF is the top mutual fund holder of Beam Therapeutics shares, with 5.18% of its total shares outstanding invested in 4.27M Beam Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools